Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer
NCT00298064 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2023-07-05
Summary
The Tissue Repository will search for cases, pull slides, Paraffin-embedded tissue (PET) blocks.
Conditions
- Cervical Cancer
- Cervix
Interventions
- GENETIC
-
Tissue Repository
Sponsors & Collaborators
-
University of New Mexico
lead OTHER
Principal Investigators
-
Claire Verschraegen, MD · University of New Mexico
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-12-31
- Primary Completion
- 2005-12-31
- Completion
- 2005-12-31
Countries
- United States
Study Locations
More Related Trials
-
Biomarkerscreening in Cervical Cancer and Its Preinvasive Lesions
NCT02238990 ·Status: ACTIVE_NOT_RECRUITING
-
Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue
NCT00250055 ·Status: TERMINATED ·Phase: NA
-
Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
NCT00299481 ·Status: UNKNOWN
-
MR Metabolic Biomarkers for Cervical Cancer
NCT01874548 ·Status: COMPLETED
-
Regression of Cervical Precancerous Lesions and Associated Risk Factors
NCT06147388 ·Status: RECRUITING
-
Cervical Cancer Screening Project Part C
NCT01575444 ·Status: TERMINATED
-
Study of Biomarkers in Gynecological Cancers
NCT03420118 ·Status: RECRUITING ·Phase: NA
-
Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial Tissue
NCT03498924 ·Status: COMPLETED
-
Using Plasma Human Papillomavirus (HPV)-Related Deoxyribonucleic Acid (DNA) and Ribonucleic Acid (RNA) to Follow Response of Cervical Cancer to Surgery, Radiation, and Chemotherapy
NCT07214584 ·Status: RECRUITING
-
An Exploratory Study of Using Magnetic Resonance Prognostic Imaging Markers for Radiotherapy In Patients With Cervix Cancer (EMPIRIC Study)
NCT05532930 ·Status: RECRUITING
-
Prognostic Markers of Gynecologic Cancers
NCT00290459 ·Status: COMPLETED
-
Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer
NCT01371695 ·Status: UNKNOWN
-
Biomarkers for Clinical Hypoxia Evaluation in Cervical Cancer
NCT05029258 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
NCT00004091 ·Status: COMPLETED
-
HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening
NCT02116920 ·Status: UNKNOWN
-
Cervical Cancer Susceptible Population Classification
NCT06405945 ·Status: RECRUITING
-
Study of a Predictor for Cervix Cancer
NCT01641484 ·Status: TERMINATED ·Phase: NA
-
Biomarkers Predictive for Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Evolvement
NCT05049252 ·Status: UNKNOWN
-
Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in Patients With Cervical Cancer
NCT03655977 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Resonance Fingerprinting for Preoperative Evaluation of Lymphovascular Space Invasion in Early Stage Cervical Cancer
NCT05808933 ·Status: RECRUITING
-
Lab-on-a-chip Detection of Cervical Cancer Tumour Markers
NCT03380741 ·Status: UNKNOWN
-
Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer
NCT00900081 ·Status: WITHDRAWN
-
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
NCT06283875 ·Status: NOT_YET_RECRUITING
-
Cervix: Hypoxia, Interstitial Fluid Pressure and GSH Levels
NCT00188539 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix
NCT05046080 ·Status: RECRUITING